Ryoichi Ishibashi
Publication Activity (10 Years)
Years Active: 2019-2024
Publications (10 Years): 16
Publications (10 Years): 16
Publications
- Ryoichi Ishibashi, Yosuke Inaba, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yuki Shiko, Yusuke Kashiwagi, Yoshiro Maezawa, Yohei Kawasaki, Eiryo Kawakami, Shuichi Yamamoto, Koutaro YokoteSodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database. Diabetes, obesity & metabolism (2024)
- Ryoichi Ishibashi, Yosuke Inaba, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yuki Shiko, Yusuke Kashiwagi, Yoshiro Maezawa, Yohei Kawasaki, Eiryo Kawakami, Shuichi Yamamoto, Koutaro YokoteSodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database. Diabetes, obesity & metabolism 26 (4) (2024)
- Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
- Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
- Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
- Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
- Yusuke Baba, Suzuka Watanabe, Saho Hayashi, Toshiki Sakai, Masamitsu Naka, Saori Kami, Kiichi Hirayama, Kazuko Koizumi, Ai Takahashi, Miwako Meguro, Ryo Iga, Yoshitaka Yamanaka, Masaaki Kataoka, Daigaku Uchida, Ryoichi Ishibashi
- Ryoichi Ishibashi, Yosuke Inaba, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yuki Shiko, Yusuke Kashiwagi, Yoshiro Maezawa, Yohei Kawasaki, Eiryo Kawakami, Shuichi Yamamoto, Koutaro YokoteSodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database. Diabetes, obesity & metabolism 26 (4) (2024)
- Ryoichi Ishibashi, Kiichi Hirayama, Suzuka Watanabe, Kosuke Okano, Yuta Kuroda, Yusuke Baba, Takuma Kanayama, Chiho Ito, Keisuke Kasahara, Saki Aiba, Ryo Iga, Ryohei Ohtani, Yosuke Inaba, Masaya Koshizaka, Yoshiro Maezawa, Koutaro Yokote
- Masaya Koshizaka, Ryoichi Ishibashi, Ko Ishikawa, Mayumi Shoji, Kana Ide, Shintaro Ide, Hisaya Kato, Naoya Teramoto, Ryo Terayama, Yoshiro Maezawa, Koutaro Yokote, null null
- Yusuke Baba, Ryoichi Ishibashi, Atsushi Takasaki, Chiho Ito, Atsuko Watanabe, Megumi Tokita, Miwako Meguro, Tomomi Harama, Kiichi Hirayama, Tetsuya Yamamoto, Susumu Nakamura, Masaya Koshizaka, Yoshiro Maezawa, Daigaku Uchida, Fumitaka Okajima
- Tetsuya Yamamoto, Kenichi Sakurai, Masahiro Watanabe, Ikki Sakuma, Nobuhisa Kanahara, Akihiro Shiina, Tadashi Hasegawa, Hiroyuki Watanabe, Masaomi Iyo, Ryoichi Ishibashi
- Atsushi Tanaka, Isao Taguchi, Hiroki Teragawa, Nobukazu Ishizaka, Yumiko Kanzaki, Hirofumi Tomiyama, Masataka Sata, Akira Sezai, Kazuo Eguchi, Toru Kato, Shigeru Toyoda, Ryoichi Ishibashi, Kazuomi Kario, Tomoko Ishizu, Shinichiro Ueda, Koji Maemura, Yukihito Higashi, Hirotsugu Yamada, Mitsuru Ohishi, Kotaro Yokote, Toyoaki Murohara, Jun-Ichi Oyama, Koichi Node, null null
- Ryoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, Tomoaki Tatsumi, Sho Takahashi, Kengo Nagashima, Noriko Asaumi, Miyuki Arai, Fumio Shimada, Kaori Tachibana, Yoshihiro Watanabe, Ko Ishikawa, Akiko Hoshino, Kyohei Yamamoto, Mariko Kubota-Taniai, Takafumi Mayama, Shuichi Yamamoto, Koutaro Yokote
- Ryoichi Ishibashi, Yusuke Baba, Kyoka Kakinuma, Atsushi Takasaki, Chihiro Hiraga, Tomomi Harama, Tetsuya Yamamoto, Susumu Nakamura, Masaya Koshizaka, Yoshiro Maezawa, Daigaku Uchida, Fumitaka Okajima
- Masaya Koshizaka, Ko Ishikawa, Ryoichi Ishibashi, Yoshiro Maezawa, Kenichi Sakamoto, Daigaku Uchida, Susumu Nakamura, Masaya Yamaga, Hidetaka Yokoh, Akina Kobayashi, Shunichiro Onishi, Kazuki Kobayashi, Jun Ogino, Naotake Hashimoto, Hirotake Tokuyama, Fumio Shimada, Emi Ohara, Takahiro Ishikawa, Mayumi Shoji, Shintaro Ide, Kana Ide, Yusuke Baba, Akiko Hattori, Takumi Kitamoto, Takuro Horikoshi, Ryota Shimofusa, Sho Takahashi, Kengo Nagashima, Yasunori Sato, Minoru Takemoto, Laura Kristin Newby, Koutaro Yokote, null nullComparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study). Diabetes, obesity & metabolism 21 (8) (2019)